Understanding Benign Prostatic Hyperplasia and Surgical Options

Benign prostatic hyperplasia (BPH) affects millions of men worldwide as they age, causing bothersome lower urinary tract symptoms that can significantly impact quality of life. Two established surgical treatments stand out for managing moderate to severe cases: holmium laser enucleation of the prostate (HoLEP) and transurethral resection of the prostate (TURP). While both effectively relieve obstruction, patients and clinicians increasingly consider potential effects on cognitive function, particularly in older adults who may already face age-related changes or comorbidities.

HoLEP uses a high-powered holmium laser to precisely remove obstructing prostate tissue through the urethra. TURP, the long-standing gold standard, employs a resectoscope to shave away excess tissue electrically. Recent research has begun exploring whether these procedures influence neurocognitive performance in the months following surgery, driven by concerns over anesthesia exposure, inflammation, and recovery processes.

The Landmark Prospective Cohort Study

A 2026 prospective observational cohort study led by Orkunt Özkaptan and colleagues directly addresses these questions. Published in the peer-reviewed journal Medicina, the research followed patients undergoing either HoLEP or TURP and rigorously tracked cognitive and psychosocial outcomes at multiple time points. The study aimed to determine if the choice of surgical technique independently affects postoperative brain function after accounting for baseline factors.

Participants underwent standardized neurocognitive assessments before surgery and at follow-up intervals, with particular attention paid to three months post-procedure. Researchers employed validated tools to measure memory, attention, executive function, and overall cognitive performance, alongside measures of anxiety, depression, and quality of life.

Key Findings on Cognitive Safety

The results offer reassuring news for patients considering either procedure. Three months after surgery, neither HoLEP nor TURP was associated with notable deterioration in cognitive performance. The surgical modality itself did not emerge as a significant predictor of changes in neurocognitive function once researchers adjusted for age, comorbidities, and other variables.

Both groups demonstrated stable or even slightly improved scores in several cognitive domains, suggesting that any perioperative stressors were transient and did not lead to lasting impairment. Psychosocial measures likewise remained largely unchanged, indicating that patients generally adapted well without increased rates of anxiety or depressive symptoms attributable to the surgery type.

These outcomes hold particular relevance for older patients and those with pre-existing mild cognitive concerns, as they highlight the overall safety profile of modern BPH surgery from a neurological standpoint.

Broader Context of Perioperative Cognitive Research

Postoperative cognitive dysfunction has been a topic of growing interest across surgical specialties. Factors such as anesthesia duration, inflammatory responses, and patient frailty can influence recovery. In urology, where procedures like HoLEP and TURP are common in older populations, understanding these risks helps guide shared decision-making.

Prior studies on TURP and general anesthesia raised questions about transient cognitive effects, but long-term data have often shown resolution. HoLEP's laser-based approach may offer advantages in reduced blood loss and shorter hospital stays, potentially supporting faster overall recovery. The new cohort study builds on this foundation by isolating neurocognitive endpoints with a prospective design.

Clinical Implications for Urologists and Patients

For practicing urologists, these findings support confident recommendation of either HoLEP or TURP based on prostate size, patient anatomy, and surgeon expertise rather than cognitive concerns alone. Counseling conversations can now include clear reassurance that both techniques carry low risk of meaningful cognitive change at the three-month mark.

Patients benefit from knowing that concerns about “brain fog” or lasting mental changes should not deter them from pursuing necessary relief from BPH symptoms. Shared decision aids incorporating these data can enhance informed consent processes in academic medical centers and community practices alike.

Photo by Avery Evans on Unsplash

Research Methodology and Strengths

The study employed a prospective cohort design, allowing real-world observation of consecutive patients without randomization biases. Standardized cognitive testing batteries provided objective data, while statistical adjustments accounted for potential confounders. Follow-up at three months captured the period when any delayed effects would likely appear.

Limitations include the observational nature (no randomization) and single-center setting, yet the robust sample and comprehensive assessments strengthen the conclusions. Future multi-center trials could further validate these results across diverse populations.

Future Directions in BPH Surgery Research

Ongoing investigations are expanding the scope to include longer-term cognitive tracking, quality-of-life metrics beyond three months, and comparisons with newer minimally invasive options. Researchers are also exploring biomarkers that might predict individual susceptibility to any perioperative cognitive shifts.

In academic settings, these questions create rich opportunities for interdisciplinary collaboration between urology, neurology, anesthesiology, and geriatrics departments. Medical trainees can engage with such studies through research rotations, contributing to evidence that directly shapes clinical guidelines.

Training the Next Generation of Urologic Surgeons

Academic medical programs play a vital role in disseminating findings like these. Residency curricula increasingly incorporate discussions of cognitive outcomes alongside traditional metrics such as symptom scores and complication rates. Simulation labs allow trainees to master both HoLEP and TURP techniques while learning to address patient concerns holistically.

Faculty positions in urology departments often emphasize research productivity in areas like perioperative outcomes. Opportunities exist for specialists interested in advancing patient-centered care through rigorous study design and publication.

Global Perspectives on Prostate Surgery

Access to advanced BPH treatments varies worldwide. In regions where HoLEP technology is expanding, training programs supported by academic partnerships help ensure safe adoption. Data on neurocognitive safety can reassure healthcare systems investing in these procedures that patient outcomes extend beyond urinary symptoms to overall well-being.

International collaborations facilitate larger cohorts and diverse demographic insights, strengthening the generalizability of findings from studies like the one by Özkaptan and team.

Actionable Takeaways for Stakeholders

• Clinicians should integrate cognitive outcome data into preoperative discussions to alleviate patient anxiety.
• Researchers can build on this cohort by examining subgroups such as those with baseline mild cognitive impairment.
• Medical students and residents gain valuable experience through involvement in outcome studies that bridge basic science and clinical care.
• Healthcare administrators can use these results to support resource allocation for both established and emerging surgical technologies.

Photo by David Trinks on Unsplash

Looking Ahead: Evidence-Based Urologic Care

The 2026 prospective cohort study provides compelling evidence that both HoLEP and TURP maintain cognitive safety in the critical three-month postoperative window. As BPH management evolves, such research reinforces the value of evidence-based practice while highlighting avenues for continued improvement in patient-centered outcomes.

Academic institutions remain central to generating, teaching, and applying this knowledge, ensuring that future generations of physicians deliver care informed by the latest rigorous findings.